Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Denis C. Guttridge D

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7276-6609; OpenAlex author ID A5088452270. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 4 papers · 2026: 2 papers

Papers 13

  1. KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment. Co-author DOI 10.1158/0008-5472.can-25-2630↗
  2. Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy. Co-author DOI 10.3390/cancers18193242↗
  3. Pancreatic Cancer Induces Population-Specific Switching of Myosin Isoforms and Discrete Activation of Cachexia Genes in Skeletal Muscle Myocytes Co-author DOI 10.1101/2025.09.01.673500↗
  4. Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Surviva… Co-author DOI 10.1200/jco-25-01631↗
  5. Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cac… Co-author DOI 10.1200/jco.23.01965↗
  6. Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer. Co-author DOI 10.3390/biom15050645↗
  7. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia. Last author DOI 10.1186/s12885-024-12104-0↗
  8. Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia. Co-author DOI 10.1002/rco2.68↗
  9. STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.26508/lsa.202201460↗
  10. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. Co-author DOI 10.1016/j.pan.2018.11.002↗
  11. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients. Last author DOI 10.1002/jcsm.12251↗
  12. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions. Co-author DOI 10.1097/mpa.0000000000000898↗
  13. Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease. Co-author DOI 10.1097/mpa.0b013e318279b87f↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael C. Ostrowski · 6 shared papers, 2022–2026 · strength 1.17
  2. Teresa A Zimmers · 5 shared papers, 2018–2025 · strength 0.82
  3. Erin E. Talbert · 5 shared papers, 2017–2024 · strength 0.57
  4. G. Aaron Hobbs · 3 shared papers, 2022–2026 · strength 0.56
  5. Victoria K. Spadafora · 2 shared papers, 2024–2026 · strength 0.42
  6. Katherine R. Pelz · 2 shared papers, 2025 · strength 0.41
  7. Susann Theile · 2 shared papers, 2025 · strength 0.41
  8. Dorte Lisbet Nielsen · 2 shared papers, 2025 · strength 0.41
  9. Julia Sidenius Johansen · 2 shared papers, 2025 · strength 0.41
  10. Olav Faisal Dajani · 2 shared papers, 2025 · strength 0.41
  11. Inna Markovna Chen · 2 shared papers, 2025 · strength 0.41
  12. Mary E. Dillhoff · 4 shared papers, 2017–2022 · strength 0.36
  13. Lu Han · 2 shared papers, 2022–2026 · strength 0.33
  14. Martin John Romeo · 2 shared papers, 2022–2024 · strength 0.33
  15. Jinghui Sun · 1 shared paper, 2026 · strength 0.30
  16. Xueliang Gao · 1 shared paper, 2026 · strength 0.30
  17. Gregory B. Lesinski · 3 shared papers, 2018–2022 · strength 0.26
  18. Reeder M. Robinson · 1 shared paper, 2025 · strength 0.24
  19. Benjamin N. Christopher · 1 shared paper, 2025 · strength 0.24
  20. John P O'Bryan · 1 shared paper, 2025 · strength 0.24
  21. Nathan G. Dolloff · 1 shared paper, 2025 · strength 0.24
  22. Jeffery M. Chakedis · 2 shared papers, 2018–2022 · strength 0.23
  23. Brittany R. Counts · 1 shared paper, 2025 · strength 0.23
  24. David F. Kashatus · 1 shared paper, 2026 · strength 0.21
  25. Christabelle Rajesh · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.